C
UTMD icon

Covestor’s Utah Medical Products UTMD Stock Holding History

Covestor’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10K Buy
152
+134
+744% +$8.44K 0.01% 1430
2025
Q4 		$1K Sell
18
-7
-28% -$406 ﹤0.01% 2185
2025
Q3 		$2K Buy
25
+2
+9% +$118 ﹤0.01% 1993
2025
Q2 		$1K Sell
23
-11
-32% -$598 ﹤0.01% 2113
2025
Q1 		$2K Sell
34
-1
-3% -$60 ﹤0.01% 1898
2024
Q4 		$2K Buy
35
+8
+30% +$517 ﹤0.01% 1947
2024
Q3 		$2K Sell
27
-1
-4% -$68 ﹤0.01% 1864
2024
Q2 		$2K Buy
28
+20
+250% +$1.36K ﹤0.01% 1895
2024
Q1 		$1K Buy
8
+4
+100% +$300 ﹤0.01% 2130
2023
Q4 		$0 Hold
4
– – ﹤0.01% 2753
2023
Q3 		$0 Hold
4
– – ﹤0.01% 2748
2023
Q2 		$0 Sell
4
-2
-33% -$188 ﹤0.01% 2685
2023
Q1 		$1K Sell
6
-1
-14% -$92 ﹤0.01% 1909
2022
Q4 		$1K Sell
7
-9
-56% -$822 ﹤0.01% 1947
2022
Q3 		$1K Buy
+16
New +$1.41K ﹤0.01% 1862

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Covestor's UTMD Position: Q1 2026 in Review

Covestor increased its Utah Medical Products (UTMD) stake by 744% in Q1 2026, buying an estimated $8.44K and bringing the position to 152 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1430.

Covestor first reported a position in UTMD in Q3 2022 and has held it in 15 quarters since. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Covestor held 152 shares of Utah Medical Products worth $10K as of Q1 2026.
  • Covestor bought 134 Utah Medical Products shares in Q1 2026, an estimated $8.44K.
  • Utah Medical Products made up 0.01% of Covestor's portfolio in Q1 2026, its #1430 holding.
  • Covestor first reported a position in Utah Medical Products in Q3 2022 and has held it in 15 quarters since.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.